zoloft tabs 50 mg/tab
مستودع ادوية الصباغ - sabbagh drug store - sertraline 50 mg/tab - 50 mg/tab
zoloft tabs 50 mg
مستودع ادوية الصباغ - sabbagh drug store - sertraline 50 mg - 50 mg
ambien cr 6.25 mg
sanofi israel ltd - zolpidem tartrate - tablets extended release - zolpidem tartrate 6.25 mg - zolpidem - zolpidem - for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset).
ambien cr 12.5 mg
sanofi israel ltd - zolpidem tartrate - tablets extended release - zolpidem tartrate 12.5 mg - zolpidem - zolpidem - for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset).
desferal 0.5 g.
novartis israel ltd - deferoxamine mesylate - powder for solution for inj/inf - deferoxamine mesylate 0.5 g/vial - deferoxamine - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.
desferal 0.5 g.
novartis israel ltd - deferoxamine mesylate - powder for solution for inj/inf - deferoxamine mesylate 0.5 g/vial - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.
desferal 0.5 g.
novartis israel ltd - deferoxamine mesylate - powder for solution for inj/inf - deferoxamine mesylate 0.5 g/vial - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.
aspirin-c 400 mg, 240 mg
شركة مستودع الأدوية الأردني - the jordan drugstore co - acetylsalicylic acid 400 mg, ascorbic acid 240 mg - 400 mg, 240 mg
differin cream 0.1%
مستودع ادوية ابن سينا - ibn cina drug store - adapalene 0.1 % - 0.1%
epiduo gel 2.5%, 0.1%
مستودع ادوية ابن سينا - ibn cina drug store - benzoyl peroxide 2.5 %, adapalene 0.1 % - 2.5%, 0.1%